Other

AbbVie hikes forecast, tops Street expectations

The drugmaker AbbVie surprised Wall Street on Friday with a third-quarter performance that turned out much better than expected and a new 2014 forecast that also extends well beyond what analysts predict.

Other

Valeant: We'll bump Allergan offer to $200 a share

The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox.

Health

Oral curcumin may protect gut function

Oral curcumin may be a viable therapy to improve intestinal barrier function changes caused by consuming a high-fat Western diet, according to a preclinical study by Virginia Commonwealth University School of Medicine researchers.

Immunology

Commensal bacteria help orchestrate immune response in lung

Studies in mice demonstrate that signals from the bacteria that harmlessly—and often beneficially—inhabit the human gastrointestinal tract boost the immune system's ability to kill a major respiratory pathogen, Klebsiella ...

Health

Study finds high protein diets lead to lower blood pressure

Adults who consume a high-protein diet may be at a lower risk for developing high blood pressure (HBP). The study, published in the American Journal of Hypertension, by researchers from Boston University School of Medicine ...

page 28 from 40